Provided by Tiger Fintech (Singapore) Pte. Ltd.

Third Harmonic Bio, Inc.

5.16
+0.03000.58%
Post-market: 5.160.00000.00%16:07 EDT
Volume:525.91K
Turnover:2.70M
Market Cap:232.74M
PE:-4.74
High:5.17
Open:5.13
Low:5.11
Close:5.13
Loading ...

Third Harmonic Bio Inc expected to post a loss of 34 cents a share - Earnings Preview

Reuters
·
21 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
20 Mar

Third Harmonic Bio, Inc. (THRD) Loses -31.61% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Zacks
·
04 Mar

Third Harmonic Bio, Inc. (THRD) Upgraded to Buy: What Does It Mean for the Stock?

Zacks
·
15 Feb

Down -39.61% in 4 Weeks, Here's Why You Should You Buy the Dip in Third Harmonic Bio, Inc. (THRD)

Zacks
·
14 Feb

Third Harmonic Bio Initiates Strategic Review, Lays Off 50% Staff Citing Competitive Landscape

Benzinga
·
13 Feb

Morgan Stanley Downgrades Third Harmonic Bio to Equalweight From Overweight, Cuts Price Target to $5 From $20

MT Newswires Live
·
12 Feb

Third Harmonic Bio, Inc.: Hold Rating Amid Strategic Uncertainty and Safety Concerns

TIPRANKS
·
12 Feb

Third Harmonic Bio Cut to Market Perform From Outperform by Raymond James

Dow Jones
·
12 Feb

Third Harmonic Bio Shares Slump After 50% Workforce Cut, Strategic Review Set

MT Newswires Live
·
11 Feb

Third Harmonic Bio, Inc. Announces Restructuring Plan

TIPRANKS
·
11 Feb

Third Harmonic Bio announces Phase 1 clinical results for THB335

TIPRANKS
·
11 Feb

Third Harmonic halting non-THB335 research, reducing workforce by 50%

TIPRANKS
·
11 Feb

Third Harmonic Bio Announces Phase 1 Clinical Results for THB335 and Provides Corporate Strategic Update

THOMSON REUTERS
·
11 Feb

Third Harmonic Bio Inc -Intends to Continue THB335 Development Activities Through First Half of 2025

THOMSON REUTERS
·
11 Feb

Third Harmonic Bio Inc -THB335 Was Generally Safe and Well Tolerated in Sad Cohorts

THOMSON REUTERS
·
11 Feb

Third Harmonic Bio Inc - THB335 Phase 1 Data Support Advancement Into Phase 2 Trial in Csu

THOMSON REUTERS
·
11 Feb

Third Harmonic Bio Inc - Company Halts Non-THB335 Research and Cuts Workforce by 50%

THOMSON REUTERS
·
11 Feb

13D Filings -- Barron's

Dow Jones
·
01 Feb

Third Harmonic Bio Inc : Jefferies Cuts Target Price to $7 From $15

THOMSON REUTERS
·
15 Jan